QuiVad

Home / Netherlands / Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 5.00% on May 21, 2018. The shaded band matches the twelve months of the first chart.

July 31, 2015 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Lakefront Biotherapeutics NV by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

689 disclosures on record for this share.
DateFund% of capitalEnd of publication
June 28, 2023Qube Research & Technologies Ltd.0.60%
June 15, 2023Qube Research & Technologies Ltd.0.59%
June 12, 2023Arrowstreet Capital, Limited Partnership1.60%
May 31, 2023Arrowstreet Capital, Limited Partnership1.50%
May 30, 2023AHL Partners LLP0.50%
May 24, 2023Arrowstreet Capital, Limited Partnership1.40%
May 19, 2023Arrowstreet Capital, Limited Partnership1.30%
May 19, 2023Marshall Wace LLP0.49%
May 16, 2023Qube Research & Technologies Ltd.0.60%
May 12, 2023Qube Research & Technologies Ltd.0.59%
May 11, 2023Marshall Wace LLP0.50%
May 9, 2023Qube Research & Technologies Ltd.0.60%
May 5, 2023Arrowstreet Capital, Limited Partnership1.20%
May 4, 2023Arrowstreet Capital, Limited Partnership1.11%
May 1, 2023Qube Research & Technologies Ltd.0.51%
April 28, 2023Arrowstreet Capital, Limited Partnership1.02%
April 28, 2023Qube Research & Technologies Ltd.0.49%
April 27, 2023Arrowstreet Capital, Limited Partnership0.91%
April 26, 2023Qube Research & Technologies Ltd.0.52%
April 20, 2023Arrowstreet Capital, Limited Partnership0.84%
April 5, 2023Arrowstreet Capital, Limited Partnership0.71%
March 30, 2023Qube Research & Technologies Ltd.0.49%
March 29, 2023Arrowstreet Capital, Limited Partnership0.61%
March 24, 2023Arrowstreet Capital, Limited Partnership0.52%
March 16, 2023Qube Research & Technologies Ltd.0.50%
January 13, 2023AHL Partners LLP0.49%
December 20, 2022AHL Partners LLP0.50%
December 15, 2022AHL Partners LLP0.49%
December 12, 2022AHL Partners LLP0.50%
November 29, 2022AHL Partners LLP0.49%
November 28, 2022AQR Capital Management, LLC0.49%
October 25, 2022AQR Capital Management, LLC0.51%
September 8, 2022AQR Capital Management, LLC0.49%
August 25, 2022AQR Capital Management, LLC0.50%
August 5, 2022AQR Capital Management, LLC0.49%
July 29, 2022AHL Partners LLP0.59%
June 23, 2022AQR Capital Management, LLC0.50%
April 5, 2022Marshall Wace LLP0.47%
April 1, 2022AHL Partners LLP0.69%
March 30, 2022Marshall Wace LLP0.58%
March 23, 2022AQR Capital Management, LLC0.49%
March 16, 2022AQR Capital Management, LLC0.50%
March 4, 2022Marshall Wace LLP0.69%
February 28, 2022Qube Research & Technologies Ltd.0.49%
February 23, 2022Marshall Wace LLP0.71%
February 10, 2022Marshall Wace LLP0.63%
February 7, 2022Marshall Wace LLP0.51%
February 3, 2022Qube Research & Technologies Ltd.0.53%
February 1, 2022Qube Research & Technologies Ltd.0.45%
January 31, 2022Qube Research & Technologies Ltd.0.70%

Download 689 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the Netherlands

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=3